Stan Wong SPDR Pharma ETF XPH-N DON'T BUY Sep 11, 2019

Pharmaceuticals tend to do well from right about now through to the end of the year. He had read where Obama care would be injecting $10 billion-$35 billion in additional profits into the pharmaceutical industry over the next 10 years.

(A Top Pick Aug 22/13. Up 14.37%.) Probably the only play that has seasonal strength through to the end of the year. Pharmaceutical stocks tend to peak right around now.

Which stocks for RESP and University in 8 years? He would use healthcares such as SPDR Health Care (XLV-N) or SPDR Pharma (XPH-N). These are in a secular bull market. You could also use Van Eck Vectors Biotech (BBH-Q). This gives you a little bit of mix of all 3 sectors. He would suggest 40% and 40% on the first 2 and maybe 20% in the Biotechs.

Pharmaceutical stocks tend to do well between August and November. Between August 13 and November 21, it tends to gain an average of 5.5%, and has been positive 80% of the time over the past 20 years. This is the period were shipments of pharmaceuticals and medicines tend to increase for the start of the cold and flu season. The 3^rd quarter tends to be the best quarter for some of these Pharma stocks. This ETF owns a wide variety of pharmaceutical stocks and not all of them are high yielding, but you tend to benefit from the seasonal strength. Dividend yield of about 0.5%.

(A Top Pick Aug 10/16. Down 12.87%.) This has been frustrating with controversies and the possibility of a Clinton presidency. Now all of that has come off, and this has gapped higher from a depressed level. It is now testing that gap support at around $39. If it can hold that, there might actually be a play here. If you own this, continue to hold as there might be some good things happening.

We have a base. It was beat up by Hillary Clinton. The sector is in a secular bull market, however. This is a good place to get your initial allocation. We come into a seasonal period soon. There is decent value.

This is in an incredibly strong trend, so be careful of the entry point. Healthcare might give a little more opportunity like the IYH-N ETF or an equal weight XLV-N ETF.